Apolipoprotein(a) gene polymorphisms (TTTTA)n and G/A-914 affect Lp(a) levels in ischemic heart disease patients from Serbia

Wiener Klinische Wochenschrift

Volumn 117, Issue 11-12, 2005, Pages 406-411

  Dinčić, Dragan ^a   Živković, Maja ^b   Stanković, Aleksandra ^b   Djurić, Tamara ^b   Vujanić, Svetlana ^a   Gligić, Branko ^a   Alavantić, Dragan ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

(TTTTA)n; Apolipoprotein(a); G A 914; Gene polymorphism; Ischemic heart disease; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MALE; NUCLEOTIDE REPEAT; PROMOTER REGION; YUGOSLAVIA;

5' FLANKING REGION; ADULT; AGED; ALLELES; APOLIPOPROTEINS; APOPROTEIN(A); EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LIPOPROTEIN(A); MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; YUGOSLAVIA;

EID: 23844448381     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-005-0358-3     Document Type: Article

References (32)

1. Schaefer EJ, Lamon-Fava S, Jenner JL, Mcnamara JR, Ordovas JM, Davis CE, et al (1994) Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid research clinics coronary primary prevention trial. J Am Med Assoc 271: 999-1003
2. Danesh J, Collins R, Peto R (2000) Lipoprotein(a) and coronary heart disease. Meta-Analysis of prospective studies. Circulation 102: 1082-1085
3. Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE (1998) Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin Chem 44: 2301-2306
4. Palumbo B, Lupattelli G, Siepi D, Bianchi A, Anniboletti PF, Blandini V, et al (2002) Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity. Wien Klin Wochenschr 114: 987-991
5. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH (1992) Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 90: 52-60
6. Kraft HG, Kochl S, Menzel HJ, Sandholzer C, Utermann G (1992) The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 90: 220-230
7. Demeester CA, Bun XD, Gray RJ, Lusis AJ, Rotter JI (1995) Genetic variation in lipoprotein(a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein(a) gene locus. Am J Hum Genet 56: 287-293
8. Utermann G (1999) Genetic architecture and evolution of the lipoprotein(a) trait. Curr Opin Lipidol 10: 133-141
9. Wade DP, Clarke JG, Lindahl GE, Liu AC, Zysow BR, Meer K, et al (1993) Genetic influences on lipoprotein(a) concentration. Biochem Soc Trans 21: 499-513
10. Malgaretti N, Acquati F, Magnaghi P, Bruno L, Pontoglio M, Rocchi M, et al (1992) Characterization by yeast artificial chromosome cloning of the linked apolipoprotein(a) and plasminogen genes and identification of the apolipoprotein(a) 5′ flanking region. Proc Natl Acad Sci USA 89: 11584-11588
11. Puckey LH, Lawn RM, Knight BL (1997) Polymorphisms in the apolipoprotein(a) gene and their relationship to allele size and plasma lipoprotein(a) concentration. Hum Mol Genet 6: 1099-1107
12. Bopp S, Kochl S, Acquati F, Magnaghi P, Petho-Schramm A, Kraft HG, et al (1995) Ten allelic apolipoprotein(a) 5′ flanking fragments exhibit comparable promoter activities in HepG2 cells. J Lipid Res 36: 1721-1728
13. Suzuki K, Kuriyama M, Saito T, Ichinose A (1997) Plasma Lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest 99: 1361-1366
14. Mooser V, Manchini FP, Bopp S, Petho-Schramm A, Guerra R, Boerwinkle E, et al (1995) Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet 4: 173-181
15. Trommsdorff M, Kochl S, Lingenhel A, Kronenberg F, Delport R, Vermaak H, et al (1995) A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest 96: 150-157
16. Rosby O, Berg K (2000) LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level. J Intern Med 247: 139-152
17. Brazier L, Tiret L, Luc G, Arveiler D, Ruidavets JB, Evans A, et al (1999) Sequence polymorphisms in the apolipoprotein(a) gene and their association with Lp(a) levels and myocardial infarction. The ECTIM study. Atherosclerosis 144: 323-333
18. Kalina A, Csaszar A, Fust G, Nagy B, Szalai C, Karadi I, et al (2001) The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)n polymorphism with coronary heart disease. Clin Chim Acta 309: 45-51
19. Wade DP, Clarke JG, Lindahl GE, Liu AC, Zysow BR, Meer K, et al (1992) 5′ control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 90: 1369-1373
20. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M (1989) Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 78: 145-150
21. Chimienti G, Lamanuzzi BL, Nardulli M, Colacicco AM, Capurso A, La Gioia R, et al (2002) APO(a) variants and lipoprotein(a) in men with or without myocardial infarction. Exp Mol Pathol 73: 28-34
22. Friedwald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of LDL cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18: 499-502
23. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, et al (1977) Analysis of human variants. Proc Natl Acad Sci USA 74: 1245-1249
24. Živković M, Stanković A, Alavantić D (2003) Pentanucleotide TTTTA and G/A-914 DNA polymorphisms in apolipoprotein(a) promoter: genotyping by single-tube PCR. Clin Chem Lab Med 41: 632-633
25. Weir BS (1996) Genetic data analysis II Sinauer, Sunderland
26. Horimoto M, Hasegawa A, Takenaka T, Fujiwara M, Inoue H, Igarashi K (2003) Long-term administration of pravastatin reduces serum lipoprotein(a) levels. Int J Clin Pharmacol Ther 41: 524-530
27. Akaike M, Azuma H, Kagawa A, Matsumoto K, Hayashi I, Tamura K, et al (2002) Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases. Clin Chem 48: 1454-1459
28. Marcovina SM, Kennedy H, Bittolo Bon G, Cazzolato G, Galli C, Casiglia E, et al (1999) Fish intake, independent of apo(a) size, accounts for lower plasma lipoprotein(a) levels in Bantu fishermen of Tanzania: the Lugalawa Study. Arterioscler Thromb Vasc Biol 19: 1250-1256
29. Holmer SR, Hengstenberg C, Kraft H-G, Mayer B, Poll M, Kurzinger S, et al (2003) Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction. Circulation 107: 696-701
30. Volkova MV, Vasina VI, Formicheva EV, Schwartz EI (1997) Comparative analysis of apo(a) gene alleles: distribution of pentanucleotide repeats in position -1373 and C/T transition in position +93 among patients with myocardial infarction and a control group in St. Petersburg, Russia. Biochem Mol Med 61: 208-213
31. Wu JH, Lee IN (2003) Studies of apolipoprotein(a) promoter from subjects with different plasma lipoprotein(a) concentrations. Clin Biochem 36: 241-246
32. Puckey L, Knight B (2003) Sequence and functional changes in a putative enchancer region upstream of the apolipoprotein(a) gene. Atherosclerosis 166: 119-127